Knoll Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Knoll Capital Management’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-100,000	Closed	-$77K	–	41
2022 Q2	$77K	Hold	100,000	–	–	0.04%	39
2022 Q1	$107K	Hold	100,000	–	–	0.07%	41
2021 Q4	$190K	Hold	100,000	–	–	0.1%	37
2021 Q3	$301K	Hold	100,000	–	–	0.15%	34
2021 Q2	$391K	Buy	+100,000	New	+$415K	0.2%	36

Other funds holding AGTC

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Knoll Capital Management's AGTC Position: Q3 2022 in Review

Knoll Capital Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2022, closing a stake of 100,000 shares — an estimated $77K sold.

Knoll Capital Management first reported a position in AGTC in Q2 2021 and held it in 5 quarters. The position peaked at $391K in Q2 2021. 45 funds tracked by Wall St. Rank hold AGTC as of Q3 2022.

Knoll Capital Management reported no remaining Applied Genetic Technologies Corporation position as of Q3 2022 after selling out during the quarter.
Knoll Capital Management sold 100,000 Applied Genetic Technologies Corporation shares in Q3 2022, an estimated $77K.
Knoll Capital Management first reported a position in Applied Genetic Technologies Corporation in Q2 2021 and held it in 5 quarters.
Knoll Capital Management's Applied Genetic Technologies Corporation position peaked at $391K in Q2 2021.
45 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2022.

Based on Knoll Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.